Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Salvemini

Showing results (161-170 of 179) with videos related to

Pageof 18
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2019
Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic painZhoumou Chen, Timothy M Doyle, Livio Luongo, et al.
Journal of Medicinal Chemistry|March 31, 2021
Structure-Activity Relationship of Heterocyclic P2Y<sub>14</sub> Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine BioisosteresYoung-Hwan Jung, Veronica Salmaso, Zhiwei Wen, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2020
GPR183-Oxysterol Axis in Spinal Cord Contributes to Neuropathic PainKathryn Braden, Luigino Antonio Giancotti, Zhoumou Chen, et al.
Journal of Medicinal Chemistry|August 14, 2020
Exploration of Alternative Scaffolds for P2Y<sub>14</sub> Receptor Antagonists Containing a Biaryl CoreYoung-Hwan Jung, Jinha Yu, Zhiwei Wen, et al.
The Journal of Biological Chemistry|May 31, 2014
The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1Kali Janes, Joshua W Little, Chao Li, et al.
Pain|August 3, 2016
The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone painLauren M Slosky, Neemah M BassiriRad, Ashley M Symons, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 22, 2020
Chronic Morphine-Induced Changes in Signaling at the A<sub>3</sub> Adenosine Receptor Contribute to Morphine-Induced Hyperalgesia, Tolerance, and WithdrawalTimothy M Doyle, Tally M Largent-Milnes, Zhoumou Chen, et al.
Brain : a Journal of Neurology|November 22, 2014
Endogenous adenosine A3 receptor activation selectively alleviates persistent pain statesJoshua W Little, Amanda Ford, Ashley M Symons-Liguori, et al.
International Journal of Molecular Sciences|July 7, 2019
Modulation of Nitric Oxide Synthases by Oxidized LDLs: Role in Vascular Inflammation and Atherosclerosis DevelopmentMicaela Gliozzi, Miriam Scicchitano, Francesca Bosco, et al.
The Journal of Clinical Investigation|February 23, 2021
Adenosine A3 agonists reverse neuropathic pain via T cell-mediated production of IL-10Mariaconcetta Durante, Silvia Squillace, Filomena Lauro, et al.
Pageof 18

Showing results (161-170 of 179) with videos related to

Sort By:
Pageof 18
Proceedings of the National Academy of Sciences of the United States of America|May 10, 2019
Sphingosine-1-phosphate receptor 1 activation in astrocytes contributes to neuropathic painZhoumou Chen, Timothy M Doyle, Livio Luongo, et al.
Journal of Medicinal Chemistry|March 31, 2021
Structure-Activity Relationship of Heterocyclic P2Y<sub>14</sub> Receptor Antagonists: Removal of the Zwitterionic Character with Piperidine BioisosteresYoung-Hwan Jung, Veronica Salmaso, Zhiwei Wen, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 11, 2020
GPR183-Oxysterol Axis in Spinal Cord Contributes to Neuropathic PainKathryn Braden, Luigino Antonio Giancotti, Zhoumou Chen, et al.
Journal of Medicinal Chemistry|August 14, 2020
Exploration of Alternative Scaffolds for P2Y<sub>14</sub> Receptor Antagonists Containing a Biaryl CoreYoung-Hwan Jung, Jinha Yu, Zhiwei Wen, et al.
The Journal of Biological Chemistry|May 31, 2014
The development and maintenance of paclitaxel-induced neuropathic pain require activation of the sphingosine 1-phosphate receptor subtype 1Kali Janes, Joshua W Little, Chao Li, et al.
Pain|August 3, 2016
The cystine/glutamate antiporter system xc- drives breast tumor cell glutamate release and cancer-induced bone painLauren M Slosky, Neemah M BassiriRad, Ashley M Symons, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 22, 2020
Chronic Morphine-Induced Changes in Signaling at the A<sub>3</sub> Adenosine Receptor Contribute to Morphine-Induced Hyperalgesia, Tolerance, and WithdrawalTimothy M Doyle, Tally M Largent-Milnes, Zhoumou Chen, et al.
Brain : a Journal of Neurology|November 22, 2014
Endogenous adenosine A3 receptor activation selectively alleviates persistent pain statesJoshua W Little, Amanda Ford, Ashley M Symons-Liguori, et al.
International Journal of Molecular Sciences|July 7, 2019
Modulation of Nitric Oxide Synthases by Oxidized LDLs: Role in Vascular Inflammation and Atherosclerosis DevelopmentMicaela Gliozzi, Miriam Scicchitano, Francesca Bosco, et al.
The Journal of Clinical Investigation|February 23, 2021
Adenosine A3 agonists reverse neuropathic pain via T cell-mediated production of IL-10Mariaconcetta Durante, Silvia Squillace, Filomena Lauro, et al.
Pageof 18